08048035968
Leading exporter of Genuine LENVA 4MG Capsules from India to Singapore - Tampines | Phoenix Exim

1. General Information

LENVA 4 mg Capsules are a prescription anticancer medicine containing lenvatinib. It is generally used as part of specialist cancer treatment and should be taken only under the supervision of a qualified healthcare professional.

Lenvatinib may be used alone or in combination with other anticancer medicines depending on the cancer being treated.

2. Product Information

  • Product: LENVA 4 mg Capsules
  • Active ingredient: Lenvatinib
  • Strength: 4 mg
  • Dosage form: Capsule
  • Therapeutic class: Antineoplastic / kinase inhibitor
  • Route: Oral
  • Prescription status: Prescription medicine
  • Manufacturer: Depends on the specific LENVA product and market
  • Storage: Store according to the product label and manufacturer's instructions.

The 4 mg strength is also used as part of certain dose-adjustment schedules when treatment requires a lower dose. The appropriate dose depends on the cancer type, treatment regimen, kidney/liver function, and tolerability.

3. Uses of LENVA 4 mg Capsules

Lenvatinib is prescribed for certain cancers, including:

  • Certain types of thyroid cancer that have returned or spread and cannot be treated adequately with radioactive iodine.
  • Certain advanced kidney cancers, including in combination with other medicines.
  • Certain liver cancers that cannot be treated surgically.
  • Certain advanced or recurrent endometrial cancers in specified treatment settings, including combination treatment with pembrolizumab.

The exact indication and combination therapy should always be determined by the treating oncologist.

4. Benefits of This Medicine

When appropriately prescribed, lenvatinib may:

  • Help slow the growth and progression of certain cancers.
  • Inhibit signaling pathways involved in cancer-cell proliferation.
  • Reduce tumor-supporting blood-vessel formation by inhibiting angiogenic signaling.
  • Be used as part of targeted treatment for several specific cancer types.
  • Provide an oral treatment option rather than an injectable administration.

The expected benefit varies according to cancer type, disease stage, previous treatment, and individual response.

5. Side Effects of LENVA 4 mg

Lenvatinib can cause side effects, and some may be serious. Important potential adverse effects include:

  • High blood pressure
  • Fatigue or weakness
  • Diarrhea
  • Nausea and vomiting
  • Reduced appetite and weight loss
  • Mouth sores
  • Abdominal pain
  • Skin reactions, including redness, rash, or peeling of the hands and feet
  • Swelling
  • Bleeding
  • Changes in thyroid function
  • Kidney or liver problems
  • Protein in the urine
  • Heart-related complications
  • Blood-clot-related events

Lenvatinib can also cause serious complications such as severe hypertension, bleeding, impaired kidney function, liver toxicity, cardiac problems, and gastrointestinal perforation or fistula.

6. Common Side Effects

Commonly reported side effects can include:

  • Tiredness
  • Decreased appetite
  • Nausea
  • Diarrhea
  • Vomiting
  • Weight loss
  • Headache
  • Abdominal discomfort or pain
  • Joint or muscle pain
  • Rash
  • Mouth sores
  • Swelling of the arms or legs
  • Changes in blood pressure
  • Hoarseness

Not everyone experiences these effects, and their severity can differ between patients.

7. How to Use LENVA 4 mg Capsules

LENVA should be taken exactly as prescribed by the oncologist.

General administration guidance for lenvatinib includes:

  • Usually taken once daily at approximately the same time.
  • May be taken with or without food.
  • Swallow capsules whole; do not crush or chew them.
  • Do not change the dose or stop treatment without consulting the prescribing doctor.
  • If a dose is missed, follow the instructions provided by the healthcare professional or product information.

The dose of lenvatinib varies considerably according to the cancer type and treatment combination. Therefore, LENVA 4 mg should not automatically be considered the standard daily dose for every patient.

8. How LENVA Works

Lenvatinib is a tyrosine kinase inhibitor (TKI). It blocks specific signaling pathways involved in tumor-cell growth and angiogenesis.

By inhibiting these pathways, lenvatinib can interfere with signals that help cancer cells multiply and with the formation of blood vessels that tumors may require for continued growth.

9. Safety Advice

  • Use LENVA only under specialist medical supervision.
  • Inform your doctor about all prescription medicines, OTC medicines, vitamins, and supplements you take.
  • Tell your doctor if you have high blood pressure, heart disease, bleeding problems, kidney disease, liver disease, thyroid problems, or previous blood-clotting problems.
  • Blood pressure should be monitored during treatment.
  • Your doctor may perform blood and urine tests to monitor treatment.
  • Seek urgent medical attention for severe chest pain, difficulty breathing, significant bleeding, severe abdominal pain, sudden neurological symptoms, or other serious symptoms.
  • Tell your healthcare provider if you become pregnant or plan to become pregnant.
  • Do not stop treatment or alter the dose without medical advice.
  • Keep the medicine out of reach of children.

Lenvatinib can require dose interruption or reduction when significant adverse reactions occur, so regular medical monitoring is important.

10. Frequently Asked Questions (FAQs)

Q1. What is LENVA 4 mg?
LENVA 4 mg is a capsule containing 4 mg of lenvatinib, a targeted anticancer medicine used for specific cancer indications.

Q2. What is LENVA 4 mg used for?
Depending on the treatment regimen, lenvatinib is used for certain thyroid, kidney, liver, and endometrial cancers.

Q3. Is LENVA 4 mg a chemotherapy medicine?
Lenvatinib is generally classified as a targeted anticancer therapy and kinase inhibitor rather than conventional cytotoxic chemotherapy.

Q4. How often is lenvatinib taken?
It is commonly taken once daily, but the prescribed dose depends on the cancer type and treatment regimen.

Q5. Can LENVA 4 mg be taken without food?
Yes. Lenvatinib can generally be taken with or without food.

Q6. Can I stop LENVA if I feel better?
No. Cancer treatment should not be stopped or changed without consulting the treating oncologist.

Q7. What should I do if I miss a dose?
Follow your doctor's or product information's missed-dose instructions. Do not take an extra dose to compensate unless specifically instructed.

Q8. Does LENVA 4 mg cause side effects?
Yes. Side effects can include fatigue, diarrhea, nausea, reduced appetite, hypertension, weight loss, and other reactions. Some adverse effects can be serious.

Q9. Is LENVA 4 mg suitable for every cancer patient?
No. Lenvatinib is indicated only for specific cancers and treatment situations. The oncologist determines whether it is appropriate.

Q10. Can LENVA be substituted with another medicine?
Only a doctor or pharmacist should determine an appropriate alternative because the active ingredient, strength, formulation, indication, and treatment regimen must be matched carefully.

11. Substitute for LENVA 4 mg

The clinically relevant alternative should generally contain lenvatinib at an appropriate strength, but products should not be substituted solely because they have a similar name or strength.

Depending on the country, alternatives may include other brands or generic formulations of lenvatinib 4 mg. The exact product selected should be confirmed by a doctor or pharmacist, particularly for oncology treatment.

Important: Lenvatinib products are not interchangeable with unrelated anticancer medicines simply because they are used for the same cancer. Treatment selection depends on the patient's diagnosis, previous therapy, combination regimen, organ function, and clinical condition.

12. SEO Keywords

  • LENVA 4 mg Capsules
  • LENVA 4 mg Capsules exporter
  • LENVA 4 mg supplier from India
  • LENVA 4 mg medicine exporter
  • Lenvatinib 4 mg Capsules
  • Lenvatinib 4 mg exporter from India
  • Lenvatinib 4 mg pharmaceutical supplier
  • Lenvatinib 4 mg oncology medicine
  • Lenvatinib Capsules supplier
  • Lenvatinib 4 mg wholesale supplier
  • LENVA 4 mg international supplier
  • LENVA 4 mg pharmaceutical exporter
  • Lenvatinib medicine exporter from Nagpur India
  • LENVA 4 mg exporter from Nagpur
  • Lenvatinib 4 mg for cancer treatment
  • Lenvatinib targeted cancer medicine
  • Lenvatinib 4 mg capsules supplier USA
  • Lenvatinib 4 mg capsules supplier UK
  • Lenvatinib 4 mg supplier Australia
  • Lenvatinib 4 mg supplier Singapore
  • Lenvatinib 4 mg supplier Canada
  • Lenvatinib 4 mg supplier South Korea
  • Lenvatinib 4 mg supplier UAE
  • LENVA 4 mg capsules international pharmaceutical supply
  • Lenvatinib 4 mg B2B pharmaceutical supplier
  • Lenvatinib 4 mg bulk pharmaceutical supplier
  • Generic Lenvatinib 4 mg supplier
  • Lenvatinib oncology medicine wholesale
  • Lenvatinib pharmaceutical exporter India
  • Phoenix Exim Lenvatinib 4 mg supplier
Aug 19th, 2026 2:27 PM

Keywords